Try our Advanced Search for more refined results
In Re Vitamin C Antitrust Litigation
Case Number:
1:06-md-01738
Court:
Nature of Suit:
Multi Party Litigation:
Multi-district Litigation
Judge:
Firms
- Amamgbo & Associates
- Baker McKenzie
- BoiesBattin
- Boies Schiller
- Cadwalader Wickersham
- Cohen Milstein
- Gibbs & Bruns
- Glancy Prongay
- Greenberg Traurig
- Gustafson Gluek
- Hausfeld LLP
- Hofheimer Gartlir
- Houser LLP
- Izower Feldman
- Johns Flaherty
- Joseph Saveri Law Firm
- Kirby McInerney
- Kobre & Kim
- Lieff Cabraser
- Massey & Gail
- Morris Laing
- Moscone Emblidge
- Orrick Herrington
- Paul Weiss
- Saveri & Saveri
- Seward & Kissel
- Sidley Austin
- Slinde Nelson
- Susman Godfrey
- Wilson Sonsini
- Zelle LLP
-
February 26, 2013
Vitamin C Maker Sought To Conceal Price-Fixing, Jury Hears
Jurors deciding the fate of Chinese vitamin C makers on trial for restricting exports and fixing prices of the nutrient were shown an internal memo Tuesday from an alleged co-conspirator urging employees to "be smart" and conceal their actions.
-
February 21, 2013
Vitamin-C Co.'s Bid To Duck Antitrust Suit Came Too Late
A New York federal judge on Wednesday denied China Pharmaceutical Group Ltd.'s bid to escape exposure for the alleged price-fixing by a vitamin C-producing subsidiary days before the antitrust case was scheduled to go to trial, saying CPG waited too long to raise issues related to its liability.
-
February 20, 2013
Vitamin C Antitrust Case Puts US-China Ties On Trial
Chinese vitamin C manufacturers will go to trial Monday after years of courtroom wrangling over whether they can be held accountable for allegedly government-sponsored price-fixing, in a case that could test the limits of international comity with a key U.S. trade partner.
-
February 08, 2013
Chinese Vitamin-C Maker Can't Escape Cartel Claims
A New York federal judge on Friday refused to dismiss putative class claims against North China Pharmaceutical Group Corp., saying there was a genuine dispute over the company's possible role in a cartel among Chinese vitamin C companies.
-
December 21, 2012
Vitamin C Price-Fixing Judge Lets Expert's Analysis Stand
A New York federal judge refused Thursday to bar an expert witness' testimony and analysis in an upcoming multidistrict litigation trial over alleged price-fixing by Chinese vitamin C manufacturers, saying any issues the plaintiffs have can be addressed during cross-examination.
-
November 21, 2012
Vitamin C Co. Needn't Yield Audit Docs In Price-Fixing MDL
The New York federal judge overseeing the vitamin C price-fixing multidistrict litigation has given China Pharmaceutical Group Co. Ltd. a reprieve from part of an ordered document search, saying it doesn't have to surrender working papers from a Deloitte & Touche LLP audit.
-
November 19, 2012
Foreign Buyer Claims Stand In Vitamin C Price-Fixing MDL
A New York federal judge refused to toss portions of a vitamin C price-fixing multidistrict litigation against a group of Chinese manufacturers on Friday, saying that the Foreign Trade Antitrust Improvements Act doesn't shield the companies from antitrust claims from foreign purchasers.
-
October 26, 2012
Vitamin C Judge Forces Chinese Co. To Hire E-Discovery Pro
A judge overseeing price-fixing litigation against several vitamin C makers ordered China Pharmaceutical Group Ltd. Thursday to hire an outside specialist to do a rigorous document search after the plaintiffs complained that the company had done a "woefully inadequate" job of searching for the information they sought.
-
October 09, 2012
Vitamin C Price-Fixing Trial Delayed By Evidence Challenges
A New York federal judge on Friday postponed the start of a trial over alleged price-fixing by a group of Chinese vitamin C manufacturers to January after a flurry of briefs were filed in recent weeks that, among other things, challenged what evidence will be permitted at the trial.
-
October 01, 2012
Vitamin C Makers Can't Use China Ministry Statements At Trial
A New York federal judge on Monday blocked Chinese vitamin C producers accused of fixing prices from using statements from China's Ministry of Commerce as evidence at trial, ruling the filings were not trustworthy enough to escape the ban on hearsay.